Population-based organized breast cancer screening has increased worldwide based in part on supporting evidence of the efficacy of mammography screening observed in randomized clinical trials conducted between 1970 and 1990
1-3 and in part on the significant global increase in breast cancer incidence. In Taiwan, the incidence rate of breast cancer doubled from 30 per 100 000 in 1995 to 59 per 100 000 in 2003.
4 Since population-based, organized service screening programs are influenced by cultural-specific factors, the infrastructure of the health care system, and economic concerns over limited resources, different approaches to breast cancer screening have been implemented, including clinical breast examination (CBE), risk-based mammography screening, and universal mammography screening.